Back
Microsoft Vs. Akero Therapeutics Industry Stock Comparison
Sell
47
MSFT
Microsoft
Last Price:
$408.39
Seasonality Move:
6.26%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$50.48
Seasonality Move:
-15.52%
Sell
47
Microsoft (MSFT)
is a Sell
Is Microsoft a Buy, Sell or Hold?
-
MSFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $50.52. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $50.52The current trend is moderately bullish and AKRO is experiencing slight buying pressure.
MSFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.76 | Sell |
Relative Strength Index (14 RSI): | 39.13 | Sell |
Chaikin Money Flow: | 14892773 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (409.44 - 435.78) | Sell |
Bollinger Bands (100): | (413.63 - 436.91) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.4 | Buy |
Relative Strength Index (14 RSI): | 64.38 | Buy |
Chaikin Money Flow: | 159620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.35 - 55.67) | Buy |
Bollinger Bands (100): | (23.98 - 41.64) | Buy |
MSFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 411.32 | Sell |
20-day SMA: | 423.12 | Sell |
50-day SMA: | 429.57 | Sell |
200-day SMA: | 426.02 | Sell |
8-day EMA: | 412.02 | Sell |
20-day EMA: | 418.31 | Sell |
50-day EMA: | 423.81 | Sell |
200-day EMA: | 418.74 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.13 | Sell |
20-day SMA: | 46.1 | Buy |
50-day SMA: | 35.26 | Buy |
200-day SMA: | 28.31 | Buy |
8-day EMA: | 50.72 | Sell |
20-day EMA: | 46.47 | Buy |
50-day EMA: | 38.98 | Buy |
200-day EMA: | 31.04 | Buy |
Microsoft Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.04 per share, an increase this year of $1.36 per share, and an increase next year of $1.86 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Microsoft Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |